secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tevogen Bio Holdings Inc. (TVGN)
CIK:        0001860871
Form:       8-K
Filed at:   2023-11-17T23:59:59+00:00
Accession:  0001493152-23-041775
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Semper Paratus furnishes investor presentation for proposed Tevogen Bio merger
------------------------------------------------------------------------------

- Presentation provides additional detail on June 28, 2023 merger agreement between SPAC and Tevogen Bio.
- Transaction involves exchange of all Tevogen Bio capital stock for Semper Paratus Class A shares.
- Closing conditions include shareholder approval, regulatory clearances, and minimum cash requirements.
- No new financial projections or material updates disclosed in this filing beyond the presentation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860871/000149315223041775/0001493152-23-041775-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860871/000149315223041775/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-041775

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer